How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
The window for American dominance in AI hasn’t closed, but it’s narrowing fast.
Researchers at Weill Cornell Medicine and Birkbeck, University of London, have identified a site where a commonly used ...